Today: 11 June 2026
Marvell stock edges higher after FTC clears Celestial AI deal — what traders watch next
22 January 2026
1 min read

Marvell stock edges higher after FTC clears Celestial AI deal — what traders watch next

New York, Jan 22, 2026, 15:34 EST — Regular session

  • MRVL shares rose roughly 0.5% in afternoon trading after the FTC approved early termination for its Celestial AI acquisition
  • Approval removes a major regulatory hurdle just before the planned first-quarter closing
  • Investors are now awaiting updates on the timeline, integration plans, and any disclosures related to shares involved in the deal

Shares of Marvell Technology edged up Thursday following the U.S. Federal Trade Commission’s decision to end the antitrust waiting period early for its proposed purchase of Celestial AI.

This approval clears a major obstacle for Marvell as it aims to expand further into data-center connectivity, a rapidly evolving segment of the AI buildout where timing and client deals often change on a dime.

Traders have a clear takeaway: regulatory uncertainties are fading, shifting attention to whether Marvell wraps up the deal on time and exactly how much revenue and dilution it will generate.

Marvell gained roughly 0.5%, trading at $82.95 in afternoon action. The wider market edged up as well, with the SPDR S&P 500 ETF rising around 0.6%, the Invesco QQQ Trust climbing about 0.7%, and the iShares Semiconductor ETF inching up 0.2%.

The FTC’s early termination database marked the Marvell Technology–Celestial AI deal as “granted” on Jan. 21. This early termination cuts short the mandatory Hart-Scott-Rodino review period before its scheduled end. https://www.ftc.gov/legal-library/browse/e…

Marvell revealed its deal with Celestial AI back in December, pegging upfront consideration at around $3.25 billion. That includes $1 billion in cash plus about 27.2 million shares of Marvell stock. The company aims to close the transaction in the first quarter of 2026, pending standard closing conditions.

Celestial’s “photonic fabric” aims to transfer data between AI chips and memory using light instead of electrical signals—a key bottleneck in large systems. Marvell CEO Matt Murphy told Reuters the company plans to become “a silicon photonics powerhouse,” taking on bigger rivals like Broadcom and Nvidia in the data-center infrastructure space. https://www.reuters.com/technology/chipmak…

The deal structure still involves several moving parts. Marvell has mentioned additional contingent consideration based on hitting certain milestones. Plus, earlier disclosures about customer-linked share warrants mean investors will watch closely to see how much future upside gets diluted through new equity issuance.

Risks remain. A slowdown in hyperscaler spending or delays in photonics adoption at scale could change the payoff timeline — and markets usually punish pricey deals that take longer to generate revenue.

Investors are now turning their attention to updates on closing and integration as Marvell prepares to release its quarterly results for the period ending Jan. 31. Nasdaq lists March 4 as the anticipated earnings announcement date.

Stock Market Today

  • What is an IPO as SpaceX Prepares for U.S. Stock Market Debut
    June 10, 2026, 6:01 PM EDT. An IPO, or Initial Public Offering, is when a private company sells shares to the public for the first time, becoming publicly traded. SpaceX, the aerospace manufacturer, is expected to make its debut on the U.S. stock market, marking one of the most anticipated IPOs in recent years. This move allows retail and institutional investors to buy equity in SpaceX, potentially impacting the space industry and tech sectors. The IPO process involves regulatory filings, pricing, and public trading, providing companies with capital for expansion. SpaceX's offering could reshape market dynamics, drawing significant investor interest given its innovations and growth trajectory.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Critical Metals CRML stock jumps as Tanbreez offtake term sheets and Greenland headlines draw buyers
Previous Story

Critical Metals CRML stock jumps as Tanbreez offtake term sheets and Greenland headlines draw buyers

Telecom Argentina (TEO) stock jumps on Banco Macro’s $75 million Personal Pay deal
Next Story

Telecom Argentina (TEO) stock jumps on Banco Macro’s $75 million Personal Pay deal

Go toTop